Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Capital Expenditures came in at $312000.0 in Q1 2026, up 563.83% year-on-year from $47000.0 in Q1 2025, and up 38.67% quarter-over-quarter from $225000.0 in Q4 2025.
Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Capital Expenditures history runs 4 years deep, the most recent figure standing at $312000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 563.83% year-over-year to $312000.0 in Q1 2026; TTM through Mar 2026 was $496000.0, a 1280.95% increase from a year earlier, with the FY2025 full-year figure at $231000.0, up 298.28% from the prior year.
- Capital Expenditures advanced to $312000.0 in Q1 2026 per CTNM's latest filing, from $225000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $312000.0 in Q1 2026 and bottomed at -$290000.0 in Q4 2024.
- The 4-year median for Capital Expenditures is $82000.0 (2024), against an average of $78076.9.
- Across the five-year window, Capital Expenditures jumped 3040.0% in 2024 and sank 203.66% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $309000.0 in 2023, then slumped by 193.85% to -$290000.0 in 2024, then soared by 177.59% to $225000.0 in 2025, then surged by 38.67% to $312000.0 in 2026.
- Per Business Quant, the three latest CTNM Capital Expenditures figures stand at $312000.0 (Q1 2026), $225000.0 (Q4 2025), and -$85000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 225,000.00 |
| Dec 31, 2025 | 225,000.00 |
| Sep 30, 2025 | -85,000.00 |
| Sep 30, 2025 | -85,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Dec 31, 2023 | 309,000.00 |